Cover Image
市場調查報告書

骨移植、替代骨:開發平台分析

Bone Grafts and Substitutes - Pipeline Review, 2015

出版商 GlobalData 商品編碼 344260
出版日期 內容資訊 英文 270 Pages
訂單完成後即時交付
價格
Back to Top
骨移植、替代骨:開發平台分析 Bone Grafts and Substitutes - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 270 Pages
簡介

本報告提供全球各國的企業、醫療機關等開發中的骨移植片及替代骨 (替代骨移植片) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各領域/各地區的詳細趨勢、各企業、各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 骨移植、替代骨:現在開發中的開發中產品 (各企業)

  • 骨移植、替代骨的開發企業:開發中產品 (各開發階段)
  • 骨移植、替代骨:各開發階段的開發中產品一覽

第5章 骨移植、替代骨的企業、產品概要

  • aap Implantate AG
    • 開發中產品及現在進行中的臨床實驗概要
  • Accelerated Orthopedic Technologies, Inc.
  • Adaptaide Inc.
  • Adocia
  • Advanced Biologics, LLC
  • Agenta Biotechnologies, Inc.
  • Allergan, Inc.
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Anika Therapeutics, Inc.
  • ApaTech Limited (Inactive)
  • Aperion Biologics Corporation
  • Arthro Kinetics AG
  • Aursos, Inc
  • Berkeley Advanced Biomaterials, Inc.
  • Bio2 Technologies, Inc.
  • Bioactive Bone Substitutes Ltd.
  • Bioregeneration Technologies, Inc
  • Bio-Scaffold International Pte Ltd
  • BioSET, Inc
  • Bioventus LLC
  • Body Organ Biomedical Corp.
  • Bone Solutions, Inc.
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Cellright Technologies, LLC
  • CeraPedics, Inc.
  • Chinese University of Hong Kong
  • Citrics Biomedical, LLC
  • CollPlant Ltd.
  • ConMed Corporation
  • CoreBone Ltd.
  • ElutInc
  • EpiBone
  • Exactech, Inc.
  • Graftoss Limited
  • Graftys SAS
  • Inion Oy
  • Innovia LLC
  • Innovoss Inc.
  • Integra LifeSciences Holdings Corporation
  • ISTO Technologies, Inc.
  • Jellagen Pty Ltd
  • kasios sas
  • Kensey Nash Corporation (Inactive)
  • Kytogenics Pharmaceuticals, Inc.
  • Lacerta Technologies GmbH
  • Mariel Therapeutics, Inc.
  • Maxigen Biotech Inc.
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • Miromatrix Medical Inc.
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • Noraker
  • NovaBone Products, LLC.
  • Nutech Medical, Inc
  • NuVasive, Inc.
  • Orthogen LLC
  • OssiFi, Inc.
  • OsteoNovus, LLC
  • PolyPid, Ltd.
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor, Inc.
  • RTI Surgical, Inc.
  • Sanofi
  • SIRAKOSS Limited
  • Soft Tissue Regeneration, Inc.
  • Soteira Inc.
  • Spineway
  • SurgaColl Technologies Ltd
  • TBF Genie Tissulaire
  • The Johns Hopkins University
  • Tissue Regeneration Systems, Inc.
  • Trinity College Dublin
  • University of California, San Diego
  • University of Edinburgh
  • University of Memphis
  • University of Nottingham's School Of Pharmacy
  • University of Pecs
  • University of South Florida
  • Wayne State University
  • Wound Management Technologies, Inc.
  • Wright Medical Group, Inc.
  • X-spine Systems, Inc.
  • Xtant Medical Holdings, Inc.

第6章 骨移植、替代骨:近來的市場趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0079EPD

GlobalData's Medical Devices sector report, "Bone Grafts and Substitutes - Pipeline Review, 2015" provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Bone Grafts and Substitutes Overview

3. Products under Development

  • 3.1. Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • 3.2. Bone Grafts and Substitutes - Pipeline Products by Segment
  • 3.3. Bone Grafts and Substitutes - Pipeline Products by Territory
  • 3.4. Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • 3.5. Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • 3.6. Bone Grafts and Substitutes - Ongoing Clinical Trials

4. Bone Grafts and Substitutes - Pipeline Products under Development by Companies

  • 4.1. Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
  • 4.2. Bone Grafts and Substitutes - Pipeline Products by Stage of Development

5. Bone Grafts and Substitutes Companies and Product Overview

  • 5.1. aap Implantate AG Company Overview
    • 5.1.1. aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Accelerated Orthopedic Technologies, Inc. Company Overview
    • 5.2.1. Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Adaptaide Inc. Company Overview
    • 5.3.1. Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Adocia Company Overview
    • 5.4.1. Adocia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Advanced Biologics, LLC Company Overview
    • 5.5.1. Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Agenta Biotechnologies, Inc. Company Overview
    • 5.6.1. Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Allergan, Inc. Company Overview
    • 5.7.1. Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Alphatec Holdings, Inc. Company Overview
    • 5.8.1. Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Amedica Corporation Company Overview
    • 5.9.1. Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Anika Therapeutics, Inc. Company Overview
    • 5.10.1. Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. ApaTech Limited (Inactive) Company Overview
    • 5.11.1. ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Aperion Biologics Corporation Company Overview
    • 5.12.1. Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Arthro Kinetics AG Company Overview
    • 5.13.1. Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Aursos, Inc Company Overview
    • 5.14.1. Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Berkeley Advanced Biomaterials, Inc. Company Overview
    • 5.15.1. Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Bio2. Technologies, Inc. Company Overview
    • 5.16.1. Bio2. Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Bioactive Bone Substitutes Ltd. Company Overview
    • 5.17.1. Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Bioregeneration Technologies, Inc Company Overview
    • 5.18.1. Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Bio-Scaffold International Pte Ltd Company Overview
    • 5.19.1. Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. BioSET, Inc Company Overview
    • 5.20.1. BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Bioventus LLC Company Overview
    • 5.21.1. Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Body Organ Biomedical Corp. Company Overview
    • 5.22.1. Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Bone Solutions, Inc. Company Overview
    • 5.23.1. Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. BoneGrafix, Inc. Company Overview
    • 5.24.1. BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. BoneSupport AB Company Overview
    • 5.25.1. BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Calcitec, Inc. Company Overview
    • 5.26.1. Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Cellright Technologies, LLC Company Overview
    • 5.27.1. Cellright Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. CeraPedics, Inc. Company Overview
    • 5.28.1. CeraPedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Chinese University of Hong Kong Company Overview
    • 5.29.1. Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Citrics Biomedical, LLC Company Overview
    • 5.30.1. Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. CollPlant Ltd. Company Overview
    • 5.31.1. CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. ConMed Corporation Company Overview
    • 5.32.1. ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. CoreBone Ltd. Company Overview
    • 5.33.1. CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. ElutInc Company Overview
    • 5.34.1. ElutInc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. EpiBone Company Overview
    • 5.35.1. EpiBone Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Exactech, Inc. Company Overview
    • 5.36.1. Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Graftoss Limited Company Overview
    • 5.37.1. Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Graftys SAS Company Overview
    • 5.38.1. Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Inion Oy Company Overview
    • 5.39.1. Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Innovia LLC Company Overview
    • 5.40.1. Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Innovoss Inc. Company Overview
    • 5.41.1. Innovoss Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Integra LifeSciences Holdings Corporation Company Overview
    • 5.42.1. Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. ISTO Technologies, Inc. Company Overview
    • 5.43.1. ISTO Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Jellagen Pty Ltd Company Overview
    • 5.44.1. Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. kasios sas Company Overview
    • 5.45.1. kasios sas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Kensey Nash Corporation (Inactive) Company Overview
    • 5.46.1. Kensey Nash Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Kytogenics Pharmaceuticals, Inc. Company Overview
    • 5.47.1. Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Lacerta Technologies GmbH Company Overview
    • 5.48.1. Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Mariel Therapeutics, Inc. Company Overview
    • 5.49.1. Mariel Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Maxigen Biotech Inc. Company Overview
    • 5.50.1. Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Medtronic plc Company Overview
    • 5.51.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Meta Biomed Co., Ltd. Company Overview
    • 5.52.1. Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Miromatrix Medical Inc. Company Overview
    • 5.53.1. Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. N2. Biomedical Company Overview
    • 5.54.1. N2. Biomedical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
    • 5.55.1. National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. Noraker Company Overview
    • 5.56.1. Noraker Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. NovaBone Products, LLC. Company Overview
    • 5.57.1. NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. Nutech Medical, Inc Company Overview
    • 5.58.1. Nutech Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. NuVasive, Inc. Company Overview
    • 5.59.1. NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. Orthogen LLC Company Overview
    • 5.60.1. Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. OssiFi, Inc. Company Overview
    • 5.61.1. OssiFi, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. OsteoNovus, LLC Company Overview
    • 5.62.1. OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. PolyPid, Ltd. Company Overview
    • 5.63.1. PolyPid, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. Promimic AB Company Overview
    • 5.64.1. Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. ReCaPP Company Overview
    • 5.65.1. ReCaPP Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. RepRegen Ltd. (Inactive) Company Overview
    • 5.66.1. RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. Revivicor, Inc. Company Overview
    • 5.67.1. Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. RTI Surgical, Inc. Company Overview
    • 5.68.1. RTI Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. Sanofi Company Overview
    • 5.69.1. Sanofi Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. SIRAKOSS Limited Company Overview
    • 5.70.1. SIRAKOSS Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71. Soft Tissue Regeneration, Inc. Company Overview
    • 5.71.1. Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72. Soteira Inc. Company Overview
    • 5.72.1. Soteira Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73. Spineway Company Overview
    • 5.73.1. Spineway Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74. SurgaColl Technologies Ltd Company Overview
    • 5.74.1. SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75. TBF Genie Tissulaire Company Overview
    • 5.75.1. TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76. The Johns Hopkins University Company Overview
    • 5.76.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77. Tissue Regeneration Systems, Inc. Company Overview
    • 5.77.1. Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.78. Trinity College Dublin Company Overview
    • 5.78.1. Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.79. University of California, San Diego Company Overview
    • 5.79.1. University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • 5.80. University of Edinburgh Company Overview
    • 5.80.1. University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.81. University of Memphis Company Overview
    • 5.81.1. University of Memphis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.82. University of Nottingham's School Of Pharmacy Company Overview
    • 5.82.1. University of Nottingham's School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.83. University of Pecs Company Overview
    • 5.83.1. University of Pecs Pipeline Products & Ongoing Clinical Trials Overview
  • 5.84. University of South Florida Company Overview
    • 5.84.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.85. Wayne State University Company Overview
    • 5.85.1. Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.86. Wound Management Technologies, Inc. Company Overview
    • 5.86.1. Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.87. Wright Medical Group, Inc. Company Overview
    • 5.87.1. Wright Medical Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.88. X-spine Systems, Inc. Company Overview
    • 5.88.1. X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.89. Xtant Medical Holdings, Inc. Company Overview
    • 5.89.1. Xtant Medical Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Bone Grafts and Substitutes- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment
  • Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory
  • Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials
  • Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
  • Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Table 9: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Bone Graft Substitute-Collagen & Peptide Combination - Product Status
  • Table 11: Bone Graft Substitute-Collagen & Peptide Combination - Product Description
  • Table 12: Jason G-Allograft - Product Status
  • Table 13: Jason G-Allograft - Product Description
  • Table 14: Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Cartilage Lesions Repair Device - Product Status
  • Table 16: Cartilage Lesions Repair Device - Product Description
  • Table 17: Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Super-Inductive DBM - Product Status
  • Table 19: Super-Inductive DBM - Product Description
  • Table 20: Adocia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: BioChaperone BMP - Degenerative Disc Disease - Product Status
  • Table 22: BioChaperone BMP - Degenerative Disc Disease - Product Description
  • Table 23: Biochaperone BMP - Non-Union Fractures - Product Status
  • Table 24: Biochaperone BMP - Non-Union Fractures - Product Description
  • Table 25: BioChaperone BMP - Osteoporosis - Product Status
  • Table 26: BioChaperone BMP - Osteoporosis - Product Description
  • Table 27: Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: OsteoMEM Synthetic Bone Graft Substitute - Product Status
  • Table 29: OsteoMEM Synthetic Bone Graft Substitute - Product Description
  • Table 30: Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: B-247 Cranial Bone Graft Implant - Product Status
  • Table 32: B-247 Cranial Bone Graft Implant - Product Description
  • Table 33: Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: SeriACL Scaffold - Product Status
  • Table 35: SeriACL Scaffold - Product Description
  • Table 36: SeriCuff Scaffold - Product Status
  • Table 37: SeriCuff Scaffold - Product Description
  • Table 38: Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Bonex - Product Status
  • Table 40: Bonex - Product Description
  • Table 41: Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Composite Silicon Nitride - Product Status
  • Table 43: Composite Silicon Nitride - Product Description
  • Table 44: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Hyalobone - Product Status
  • Table 46: Hyalobone - Product Description
  • Table 47: Hyalonect - Product Status
  • Table 48: Hyalonect - Product Description
  • Table 49: ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Synthetic Bone Graft - Orthopaedic - Product Status
  • Table 51: Synthetic Bone Graft - Orthopaedic - Product Description
  • Table 52: Synthetic Bone Graft - Spinal - Product Status
  • Table 53: Synthetic Bone Graft - Spinal - Product Description
  • Table 54: Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Z-Lig ACLR - Product Status
  • Table 56: Z-Lig ACLR - Product Description
  • Table 57: Z-Lig BT - Product Status
  • Table 58: Z-Lig BT - Product Description
  • Table 59: Z-Lig BTB - Product Status
  • Table 60: Z-Lig BTB - Product Description
  • Table 61: Z-Lig ST - Product Status
  • Table 62: Z-Lig ST - Product Description
  • Table 63: Aperion Biologics Corporation - Ongoing Clinical Trials Overview
  • Table 64: Z-Lig ACLR - A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments
  • Table 65: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: CaReS plus - Product Status
  • Table 67: CaReS plus - Product Description
  • Table 68: Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: AUR-84 Resorbable Implant - Product Status
  • Table 70: AUR-84 Resorbable Implant - Product Description
  • Table 71: Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: CPA Ceramics - Product Status
  • Table 73: CPA Ceramics - Product Description
  • Table 74: HAP Ceramics - Product Status
  • Table 75: HAP Ceramics - Product Description
  • Table 76: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Hammertoe Intramedullary Fusion Device - Product Status
  • Table 78: Hammertoe Intramedullary Fusion Device - Product Description
  • Table 79: Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: ARTEBONE - Product Status
  • Table 81: ARTEBONE - Product Description
  • Table 82: Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: InMotion - Product Status
  • Table 84: InMotion - Product Description
  • Table 85: Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Status
  • Table 87: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Description
  • Table 88: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Status
  • Table 89: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Description
  • Table 90: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Status
  • Table 91: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Description
  • Table 92: BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: AMPLEX Osteo-Promotive Bone Graft System - Cervical Spine Fusion - Product Status
  • Table 94: AMPLEX Osteo-Promotive Bone Graft System - Cervical Spine Fusion - Product Description
  • Table 95: AMPLEX Osteo-Promotive Bone Graft System - Foot & Ankle Fusion - Product Status
  • Table 96: AMPLEX Osteo-Promotive Bone Graft System - Foot & Ankle Fusion - Product Description
  • Table 97: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Status
  • Table 98: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Description
  • Table 99: BioSET, Inc - Ongoing Clinical Trials Overview
  • Table 100: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety and Preliminary Effectiveness Of Prefix Compared To Iliac Crest Bone In Subjects With DDD Undergoing Transforaminal Lumbar Interbody Fusion
  • Table 101: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety and Preliminary Effectiveness Of Prefix Compared To Iliac Crest Bone In Subjects With DDD Undergoing Transforaminal Lumbar Interbody Fusion
  • Table 102: AMPLEX Osteo-Promotive Bone Graft System - Foot & Ankle Fusion - A Multi-Center, Randomized, Pilot Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery
  • Table 103: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: OsteoAMP - Concentrate - Product Status
  • Table 105: OsteoAMP - Concentrate - Product Description
  • Table 106: OsteoAMP - Structural - Product Status
  • Table 107: OsteoAMP - Structural - Product Description
  • Table 108: Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: BioBone Filler - Product Status
  • Table 110: BioBone Filler - Product Description
  • Table 111: Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: Osteocrete - Bone Anchor - Product Status
  • Table 113: Osteocrete - Bone Anchor - Product Description
  • Table 114: OsteoCrete - Cranial - Product Status
  • Table 115: OsteoCrete - Cranial - Product Description
  • Table 116: OsteoCrete - Maxillofacial - Product Status
  • Table 117: OsteoCrete - Maxillofacial - Product Description
  • Table 118: OsteoCrete - Non Load Bearing Spine - Product Status
  • Table 119: OsteoCrete - Non Load Bearing Spine - Product Description
  • Table 120: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Solid Bone Block - Product Status

List of Figures

  • Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
  • Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment
  • Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory
  • Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
  • Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
  • Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials
Back to Top